Arhinia, choanal atresia, and microphthalmia
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
We find that FSHD and BAMS patient's cells carrying SMCHD1 mutations are both permissive for DUX4 expression, a transcription factor whose regulation has been proposed as the main trigger for FSHD.
|
30698748 |
2019 |
Arhinia, choanal atresia, and microphthalmia
|
0.750 |
Biomarker
|
disease |
BEFREE |
Identification of recurrent variants suggests disease-specific residues for FSHD2 and in BAMS, consistent with a largely disease-specific localisation of variants in SMCHD1.
|
31243061 |
2019 |
Arhinia, choanal atresia, and microphthalmia
|
0.750 |
GeneticVariation
|
disease |
UNIPROT |
These data demonstrated that FSHD2 mutations only result in decreased ATP hydrolysis, whereas many BAMS mutations can result in elevated ATPase activity and decreased eye size in <i>Xenopus</i> Interestingly, a mutation reported in both an FSHD2 patient and a BAMS patient results in increased ATPase activity and a smaller <i>Xenopus</i> eye size.
|
29748383 |
2018 |
Arhinia, choanal atresia, and microphthalmia
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
Here, we have assessed the effect of <i>SMCHD1</i> missense mutations from FSHD2 and BAMS patients on ATP hydrolysis activity and protein conformation and the effect of BAMS mutations on craniofacial development in a <i>Xenopus</i> model.
|
29748383 |
2018 |
Arhinia, choanal atresia, and microphthalmia
|
0.750 |
GeneticVariation
|
disease |
UNIPROT |
SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.
|
28067909 |
2017 |
Arhinia, choanal atresia, and microphthalmia
|
0.750 |
Biomarker
|
disease |
CTD_human |
We report here that missense mutations in the epigenetic regulator SMCHD1 mapping to the extended ATPase domain of the encoded protein cause BAMS in all 14 cases studied.
|
28067911 |
2017 |
Arhinia, choanal atresia, and microphthalmia
|
0.750 |
Biomarker
|
disease |
CTD_human |
SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.
|
28067909 |
2017 |
Arhinia, choanal atresia, and microphthalmia
|
0.750 |
CausalMutation
|
disease |
CLINVAR |
SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.
|
28067909 |
2017 |
Arhinia, choanal atresia, and microphthalmia
|
0.750 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.
|
28067909 |
2017 |
Arhinia, choanal atresia, and microphthalmia
|
0.750 |
GeneticVariation
|
disease |
UNIPROT |
We report here that missense mutations in the epigenetic regulator SMCHD1 mapping to the extended ATPase domain of the encoded protein cause BAMS in all 14 cases studied.
|
28067911 |
2017 |
Arhinia, choanal atresia, and microphthalmia
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
We report here that missense mutations in the epigenetic regulator SMCHD1 mapping to the extended ATPase domain of the encoded protein cause BAMS in all 14 cases studied.
|
28067911 |
2017 |
Arhinia, choanal atresia, and microphthalmia
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.
|
28067909 |
2017 |